ASM Health-CCMID-UCLA 

Clinical Metagenomic Technology Symposium


May 18 – 19, 2026 | Los Angeles, CA

Due to tremendous advances in genomic sequencing, clinical metagenomics and multi‑omics approaches are poised to revolutionize diagnostics for infectious diseases. The purpose of this symposium is to bring together researchers, clinicians, and developers working on clinical metagenomic NGS diagnostics to share best practices, emerging technologies, and real‑world implementation experiences.

The symposium will also explore key challenges and paths forward for clinical validation, regulatory considerations, and responsible translation of metagenomic NGS diagnostic technologies. This meeting builds upon a successful prior symposium held in May 2024 and reflects growing momentum in the field toward clinical adoption.

This symposium is co‑hosted by ASM Health and the Consortium for Clinical Metagenomics in Infectious Diseases (CCMID), highlighting a shared commitment to advancing rigorous, clinically actionable mNGS diagnostics.

About ASM Health:

ASM Health convenes scientists, clinicians, industry, and policymakers to translate microbial science into clinically validated, real‑world solutions for infectious disease and public health. Through its Integrated Multi‑Omics Powered Ecosystem, ASM Health advances a multi‑omics initiative that integrates metagenomic NGS with host‑response and computational data to enable clinically actionable diagnostics, prognostics, and surveillance. 

 About CCMID:

The CCMID addresses current barriers to the use of metagenomics and NGS approaches for infectious disease diagnostics with the primary goal of advancing the field as a whole. CCMID efforts focus on field need assessments / gap analyses, education, best-use recommendations / guideline development, methodology advancement, and ultimately clinical trials.

Confirmed Speakers:

Valerie Arboleda, UCLA

John Barnes, CDC

Sivan Bercovici, Karius

Keith Brown, Riptide Genome Technology Consulting

Carrie Byington, UCSD

Charles Chiu, UCSF

Russ Corbett, UCSC

Paul Eder, NIAID

Jonathan Edgeworth, Oxford Nanopore

Eleazar Eskin, UCLA

Nick Gauthier, BugSeq

Wei Gu, Stanford

Crystal Jaing, LLNL

Jason Kralj, NIST

Eun Mi Lee, BARDA

Steve Miller, Delve Bio and CCMID

Dev Mittar, American Society for Microbiology

Robert Schlaberg, Illumina

Daniel Weisenberger, NIH Human Virome Project (UCLA)

Shangxin Yang, UCLA

Registration:

Please register using the following link: https://forms.gle/Em4i3GyE5YZtgzbG8. After submitting the registration form, you will receive an email containing a link to pay the $250 registration fee.

Where:

This event will be held in person at UCLA in the Laureate Room at the Luskin Conference Center, located at 425 Westwood Plaza, Los Angeles, CA 90095.

Luskin Conference Center ( Room promo rate)

If you are interested in securing accommodations at the Luskin Conference Center, where the symposium will be held, please use the link below to obtain the discounted room rate.

LCC Special Event Promo Rate

Parking:

https://luskinconferencecenter.ucla.edu/about/campus-map-parking/ 

CCMID

DAY 1 | May 18, 2026

Clinical Metagenomics Technology

8:30 – 8:45 am Opening Remarks and Symposium Goals, 
Eleazar Eskin, Steve Miller

8:45 – 9:00 am Carrie Byington, UCSD

9:00 – 9:30 am Sivan Bercovici, Karius

9:30 – 10:00 am Jonathan Edgeworth, Oxford Nanopore

10:00 – 10:30 am Eleazar Eskin, UCLA

10:30 – 11:00 am BREAK

11:00 – 11:30 am Shangxin Yang, UCLA

11:30 – 12:00 pm Charles Chiu, UCSF

12:00 – 1:30 pm LUNCH

1:30 – 2:00 pm Keith Brown, RGTC

2:00 – 2:30 pm Wei Gu, Stanford

2:30 – 3:00 pm Dev Mittar, ASM

3:00 - 3:30pm BREAK

3:30 – 4:00 pm Valerie Arboleda, UCLA

4:00 pm Reception | Poster Session

6:30 pm Speaker Dinner

DAY 2 | May 19, 2026

Clinical Metagenomics Bioinformatics/ Funding, Regulatory and Commercialization

8:30 am Tour of SwabSeq Lab (Meet by Laureate Room at Luskin)

9:30 – 10:00 am Steve Miller, Delve Bio

10:00 – 10:30 am Crystal Jaing, LLNL

10:30 – 11:00 am Break

11:00 – 11:15 am John Barnes, CDC

11:15 – 11:30 am Eun Mi Lee, BARDA

11:30 – 11:45 am Jason Kralj, NIST

11:45 – 12:00 pm Paul Eder, NIAID

12:00 – 12:15 pm Daniel Weisenberger, UCLA (NIH Human Virome Project)

12:15 - 1:30 pm Lunch

1:30 - 2:00 pm Robert Schlaberg, Illumina

2:00 – 2:30 pm Russ Corbett, UCSC

2:30 – 3:00 pm Nick Gauthier, BugSeq

3:00 – 4:00 pm Panel Discussion:

                        Sivan Bercovici, Karius

                        Jonathan Edgeworth, Oxford Nanopore

                        Dev Mittar, ASM

4:00 pm Closing Remarks